RESUMEN
BACKGROUND: No data are available on the incidence of drug hypersensitivity (DH) reactions in outpatient settings of tertiary allergy/immunology clinics. Our aims were to document the frequency of outpatient hospital admissions due to DH reactions to allergy/immunology clinics in adults and the management of these reactions in real life. We also investigated whether drug allergy affected social and medical behaviours of the patients. METHODS: This multi-centre study was performed for one year with the participation of 11 out of 16 tertiary allergy/clinical immunology clinics in Turkey. The study group consisted of the patients with DH reactions. Results of a questionnaire including drug reactions and management were recorded. RESULTS: Among 54,863 patients, 1000 patients with DH were enrolled with a median of 2.1% of all admissions. In real life conditions, the majority of approaches were performed for finding safe alternatives (65.5%; 1102 out of 1683) with 11.7% positivity. Diagnostic procedures were positive in 27% (154/581) of the patients. The majority of the patients had higher VAS scores for anxiety. A total of 250 subjects (25%) reported that they delayed some medical procedures because of DH. CONCLUSION: Our results documented the frequency of admissions due to DH reactions to allergy/clinical immunology clinics for the first time. Although physicians mostly preferred to perform drug tests in order to find safe alternatives, considering the fact that DH was confirmed in 27% of the patients, use of diagnostic tests should be encouraged, if no contraindication exists in order to avoid mislabelling patients as DH
No disponible
Asunto(s)
Humanos , Hipersensibilidad a las Drogas/epidemiología , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Turquía/epidemiología , /estadística & datos numéricos , Pruebas Cutáneas , Encuestas Epidemiológicas/estadística & datos numéricosRESUMEN
BACKGROUND: No data are available on the incidence of drug hypersensitivity (DH) reactions in outpatient settings of tertiary allergy/immunology clinics. Our aims were to document the frequency of outpatient hospital admissions due to DH reactions to allergy/immunology clinics in adults and the management of these reactions in real life. We also investigated whether drug allergy affected social and medical behaviours of the patients. METHODS: This multi-centre study was performed for one year with the participation of 11 out of 16 tertiary allergy/clinical immunology clinics in Turkey. The study group consisted of the patients with DH reactions. Results of a questionnaire including drug reactions and management were recorded. RESULTS: Among 54,863 patients, 1000 patients with DH were enrolled with a median of 2.1% of all admissions. In real life conditions, the majority of approaches were performed for finding safe alternatives (65.5%; 1102 out of 1683) with 11.7% positivity. Diagnostic procedures were positive in 27% (154/581) of the patients. The majority of the patients had higher VAS scores for anxiety. A total of 250 subjects (25%) reported that they delayed some medical procedures because of DH. CONCLUSION: Our results documented the frequency of admissions due to DH reactions to allergy/clinical immunology clinics for the first time. Although physicians mostly preferred to perform drug tests in order to find safe alternatives, considering the fact that DH was confirmed in 27% of the patients, use of diagnostic tests should be encouraged, if no contraindication exists in order to avoid mislabelling patients as DH.
Asunto(s)
Trastornos de Ansiedad/epidemiología , Hipersensibilidad a las Drogas/epidemiología , Hospitales Especializados/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Atención Terciaria de Salud/estadística & datos numéricos , Administración Oral , Adulto , Alérgenos/efectos adversos , Alérgenos/inmunología , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/uso terapéutico , Hipersensibilidad a las Drogas/diagnóstico , Femenino , Humanos , Inmunización , Masculino , Percepción , Turquía , beta-Lactamas/efectos adversos , beta-Lactamas/uso terapéuticoRESUMEN
Background: There are no country-based data focused on aspirin (ASA)-exacerbated respiratory disease (AERD) in Turkey. Objective: To assess the prevalence of AERD in adult patients with asthma. Methods: A structured questionnaire was administered via face-to-face interview by a specialist in pulmonology/allergy at seven centres across Turkey. Results: A total of 1344 asthma patients (F/M: 1081/263: 80.5%/19.5%, mean age: 45.7±14.2 years) were enrolled. Atopy rate was 47%. Prevalence of allergic rhinitis, chronic rhinosinusitis/rhinitis, and nasal polyposis (NP) were 49%, 69% and 20%, respectively. Of 270 patients with NP, 171 (63.3%) reported previous nasal polypectomy and 40 (25%) had a history of more than three nasal polypectomies. Aspirin hypersensitivity was diagnosed in 180 (13.6%) asthmatic patients, with a reliable history in 145 (80.5%), and oral ASA provocation test in 35(19.5%) patients. Clinical presentations of ASA hypersensitivity were respiratory in 76% (n = 137), respiratory/cutaneous in 15% (n = 27), and systemic in 9% (n = 16) of the patients. Multivariate analysis indicated that a family history of ASA hypersensitivity (p: 0.001, OR: 3.746,95% CI: 1.769-7.929), history of chronic rhinosinusitis/rhinitis (p: 0.025, OR: 1.713, 95% CI:1.069- 2.746) and presence of NP (p < 0.001, OR: 7.036, 95% CI: 4.831---10.247) were independent predictors for AERD(AU)
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Hipersensibilidad a las Drogas/epidemiología , Aspirina/efectos adversos , Asma Inducida por Aspirina/epidemiología , Turquía/epidemiología , Estudios TransversalesRESUMEN
BACKGROUND: There are no country-based data focused on aspirin (ASA)-exacerbated respiratory disease (AERD) in Turkey. OBJECTIVE: To assess the prevalence of AERD in adult patients with asthma. METHODS: A structured questionnaire was administered via face-to-face interview by a specialist in pulmonology/allergy at seven centres across Turkey. RESULTS: A total of 1344 asthma patients (F/M: 1081/263: 80.5%/19.5%, mean age: 45.7 ± 14.2 years) were enrolled. Atopy rate was 47%. Prevalence of allergic rhinitis, chronic rhinosinusitis/rhinitis, and nasal polyposis (NP) were 49%, 69% and 20%, respectively. Of 270 patients with NP, 171 (63.3%) reported previous nasal polypectomy and 40 (25%) had a history of more than three nasal polypectomies. Aspirin hypersensitivity was diagnosed in 180 (13.6%) asthmatic patients, with a reliable history in 145 (80.5%), and oral ASA provocation test in 35 (19.5%) patients. Clinical presentations of ASA hypersensitivity were respiratory in 76% (n=137), respiratory/cutaneous in 15% (n=27), and systemic in 9% (n=16) of the patients. Multivariate analysis indicated that a family history of ASA hypersensitivity (p: 0.001, OR: 3.746, 95% CI: 1.769-7.929), history of chronic rhinosinusitis/rhinitis (p: 0.025, OR: 1.713, 95% CI: 1.069-2.746) and presence of NP (p<0.001, OR: 7.036, 95% CI: 4.831-10.247) were independent predictors for AERD. CONCLUSION: This cross-sectional survey showed that AERD is highly prevalent among adult asthmatics and its prevalence seems to be affected by family history of ASA hypersensitivity, history of rhinosinusitis and presence of NP.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Aspirina/efectos adversos , Enfermedades Respiratorias/epidemiología , Enfermedades Respiratorias/fisiopatología , Adulto , Asma/epidemiología , Asma/fisiopatología , Asma Inducida por Aspirina/epidemiología , Estudios Transversales , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pólipos Nasales/epidemiología , Pólipos Nasales/fisiopatología , Prevalencia , Pronóstico , Rinitis/epidemiología , Rinitis/fisiopatología , Factores de Riesgo , Sinusitis/epidemiología , Sinusitis/fisiopatología , Turquía/epidemiologíaAsunto(s)
Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Anticuerpos Monoclonales/efectos adversos , Antirreumáticos/efectos adversos , Artritis Reumatoide/tratamiento farmacológico , Desensibilización Inmunológica/métodos , Hipersensibilidad a las Drogas/terapia , Inmunosupresores/uso terapéutico , Adalimumab , Adulto , Amlodipino/administración & dosificación , Amlodipino/uso terapéutico , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados , Anticuerpos Monoclonales de Origen Murino/farmacología , Antirreumáticos/inmunología , Antirreumáticos/uso terapéutico , Artritis Reumatoide/inmunología , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/inmunología , Etanercept , Femenino , Humanos , Hipertensión/inducido químicamente , Hipertensión/prevención & control , Inmunoglobulina G/efectos adversos , Inmunoglobulina G/uso terapéutico , Inmunosupresores/efectos adversos , Inmunosupresores/inmunología , Inmunosupresores/farmacología , Metilprednisolona/administración & dosificación , Metilprednisolona/uso terapéutico , Feniramina/administración & dosificación , Feniramina/uso terapéutico , Premedicación , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Rituximab , Factor de Necrosis Tumoral alfa/antagonistas & inhibidoresRESUMEN
Background: Crimean-Congo haemorrhagic fever (CCHF) is an acute, tick-borne viral disease. In temperate areas, CCHF cases occur between spring and early autumn when tick activity is high. This period is also the pollen season during which symptoms of allergic diseases are exacerbated. Viruses induce inflammatory and antiviral responses by binding to specific receptors on the surface of airway epithelial cells, resulting in activation of innate immune responses; release of mediators such as cytokines and chemokines; and recruitment of neutrophils and mononuclear cells to the area. Aim: We aimed to evaluate the frequency of self-reported allergic diseases and the effect on CCHF severity. Method: Between June and August 2008, a questionnaire was applied to 114 CCHF (+) patients and 122 healthy control subjects, 16 to 88 years old who attended the Infectious Diseases clinic and were hospitalised with CCHF suspected, by face to face interview including history of allergic rhinitis (AR), asthma symptoms and non specific bronchial reactivity, doctor diagnosed AR and/or asthma, and familial allergic diseases history. Results: According to PCR and/or enzyme-linked immunoassay (ELISA) results, 51.7% of patients (n=114) had CCHF. There was no significant relation between CCHF and history of AR, asthma symptoms and non specific bronchial reactivity, doctor diagnosed AR and/or asthma, and familial allergic diseases history. The severity of CCHF has not affected these parameters (p>.05). Of patients with positive CCHF test, 2.6% (n=3) and 3.5% (n=4) had doctor diagnosed AR and asthma, respectively. Conclusion: Self-reported allergic diseases and CCHF are not related with each other (AU)
No disponible
Asunto(s)
Humanos , Hipersensibilidad/complicaciones , Fiebre Hemorrágica de Crimea/complicaciones , Asma/complicaciones , Virus de la Fiebre Hemorrágica de Crimea-Congo/aislamiento & purificación , Estudios de Casos y Controles , Distribución por Edad y Sexo , Encuestas y CuestionariosRESUMEN
BACKGROUND: Crimean-Congo haemorrhagic fever (CCHF) is an acute, tick-borne viral disease. In temperate areas, CCHF cases occur between spring and early autumn when tick activity is high. This period is also the pollen season during which symptoms of allergic diseases are exacerbated. Viruses induce inflammatory and antiviral responses by binding to specific receptors on the surface of airway epithelial cells, resulting in activation of innate immune responses; release of mediators such as cytokines and chemokines; and recruitment of neutrophils and mononuclear cells to the area. AIM: We aimed to evaluate the frequency of self-reported allergic diseases and the effect on CCHF severity. METHOD: Between June and August 2008, a questionnaire was applied to 114 CCHF (+) patients and 122 healthy control subjects, 16 to 88 years old who attended the Infectious Diseases clinic and were hospitalised with CCHF suspected, by face to face interview including history of allergic rhinitis (AR), asthma symptoms and nonspecific bronchial reactivity, doctor diagnosed AR and/or asthma, and familial allergic diseases history. RESULTS: According to PCR and/or enzyme-linked immunoassay (ELISA) results, 51.7% of patients (n=114) had CCHF. There was no significant relation between CCHF and history of AR, asthma symptoms and nonspecific bronchial reactivity, doctor diagnosed AR and/or asthma, and familial allergic diseases history. The severity of CCHF has not affected these parameters (p>.05). Of patients with positive CCHF test, 2.6% (n=3) and 3.5% (n=4) had doctor diagnosed AR and asthma, respectively. CONCLUSION: Self-reported allergic diseases and CCHF are not related with each other.
Asunto(s)
Virus de la Fiebre Hemorrágica de Crimea-Congo/inmunología , Fiebre Hemorrágica de Crimea/inmunología , Mucosa Respiratoria/metabolismo , Rinitis Alérgica Estacional/inmunología , Adolescente , Adulto , Anciano , Movimiento Celular , Citocinas/metabolismo , Femenino , Virus de la Fiebre Hemorrágica de Crimea-Congo/patogenicidad , Fiebre Hemorrágica de Crimea/complicaciones , Fiebre Hemorrágica de Crimea/epidemiología , Fiebre Hemorrágica de Crimea/patología , Fiebre Hemorrágica de Crimea/fisiopatología , Humanos , Inmunidad Innata , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/patología , Masculino , Persona de Mediana Edad , Neutrófilos/metabolismo , Neutrófilos/patología , Prevalencia , Mucosa Respiratoria/inmunología , Mucosa Respiratoria/patología , Mucosa Respiratoria/virología , Rinitis Alérgica Estacional/complicaciones , Rinitis Alérgica Estacional/epidemiología , Rinitis Alérgica Estacional/patología , Rinitis Alérgica Estacional/fisiopatología , Estaciones del Año , Autorrevelación , Encuestas y Cuestionarios , Acoplamiento ViralRESUMEN
BACKGROUND: The popularity of complementary and alternative medicine (CAM), particularly for chronic diseases such as asthma, is growing rapidly, but little is known about the characteristics of CAM use by patients with asthma and chronic obstructive pulmonary diseases (COPD). The aim of the present study is to compare the knowledge and preferences of patients with asthma or COPD about CAM, to evaluate the extent, characteristics and possible predictors of CAM use. METHODS: A face-to-face interview questionnaire was administered to the patients who attended the Allergic Diseases and Chest Diseases clinics between May 2005-January 2006, and 364 patients answered the questionnaire. RESULTS: 43.1 % (n = 90) of the 209 asthmatic patients, and 43.2 % (n = 67) of the 155 COPD patients had used some type of CAM previously. The asthmatic patients who have been admitted to the Emergency Room(ER) more frequently tend to use CAM methods (p = 0.03), whereas duration of doctor diagnosis, hospitalizations, admissions to ER and to be educated for diseases have a higher impact on CAM use in COPD patients (p = 0.00, p = 0.00, p = 0.00 and p = 0.04, respectively). The most commonly used forms of CAM were herbal medicines (57.8 % vs. 70.1 %) and quail egg (46.7 % vs. 37.3 %) in patients with asthma and COPD, respectively. The reported frequency of the subjective sense of improvement was higher in asthmatic patients than COPD patients but this difference was insignificant (50.0 % vs.39.4 %; p = 0.24). CONCLUSION: Most of the patients with asthma or COPD prefer alternative medicine. CAM use by patients with COPD should be asked about by their doctors, strongly advised about continuing their medicines and about side effects of CAM.
Asunto(s)
Asma/psicología , Terapias Complementarias/psicología , Enfermedad Pulmonar Obstructiva Crónica/psicología , Adulto , Animales , Asma/terapia , Terapias Complementarias/estadística & datos numéricos , Coturnix , Huevos , Femenino , Conocimientos, Actitudes y Práctica en Salud , Miel , Humanos , Hipersensibilidad Inmediata/psicología , Hipersensibilidad Inmediata/terapia , Masculino , Persona de Mediana Edad , Fitoterapia/psicología , Fitoterapia/estadística & datos numéricos , Enfermedad Pulmonar Obstructiva Crónica/terapia , Encuestas y CuestionariosRESUMEN
Background: The popularity of complementary and alternative medicine (CAM), particularly for chronic diseases such as asthma, is growing rapidly, but little is known about the characteristics of CAM use by patients with asthma and chronic obstructive pulmonary diseases (COPD). The aim of the present study is to compare the knowledge and preferences of patients with asthma or COPD about CAM, to evaluate the extent, characteristics and possible predictors of CAM use. Methods: A face-to-face interview questionnaire was administered to the patients who attended the Allergic Diseases and Chest Diseases clinics between May 2005-January 2006, and 364 patients answered the questionnaire. Results: 43.1 % (n = 90) of the 209 asthmatic patients, and 43.2 % (n = 67) of the 155 COPD patients had used some type of CAM previously. The asthmatic patients who have been admitted to the Emergency Room(ER) more frequently tend to use CAM methods (p = 0.03), whereas duration of doctor diagnosis, hospitalizations, admissions to ER and to be educated for diseases have a higher impact on CAM use in COPD patients (p = 0.00, p = 0.00, p = 0.00 and p = 0.04, respectively). The most commonly used forms of CAM were herbal medicines (57.8 % vs. 70.1 %) and quail egg (46.7 % vs. 37.3 %) in patients with asthma and COPD, respectively. The reported frequency of the subjective sense of improvement was higher in asthmatic patients than COPD patients but this difference was insignificant (50.0 % vs.39.4 %; p = 0.24). Conclusion: Most of the patients with asthma or COPD prefer alternative medicine. CAM use by patients with COPD should be asked about by their doctors, strongly advised about continuing their medicines and about side effects of CAM
No disponible
Asunto(s)
Masculino , Femenino , Adulto , Persona de Mediana Edad , Humanos , Asma/terapia , Enfermedad Pulmonar Obstructiva Crónica/terapia , Terapias Complementarias/métodos , Encuestas y Cuestionarios , Fitoterapia/métodos , Plantas MedicinalesRESUMEN
BACKGROUND: Apoptosis may be important in limiting airway eosinophilia. Treatment with leukotriene antagonists decreases the number of eosinophils in both peripheral blood and sputum. AIM: To assess the effect of montelukast on eosinophil apoptosis in a group of patients with mild persistent asthma (MPA) and to compare this effect with the apoptotic effect of fluticasone propionate (FP). METHODS: Randomly selected patients with MPA (n = 22) who had not taken anti-inflammatory therapy within the preceding 12 months were included in the study. The sputum induction procedure was performed and the patients were divided into two groups: group 1 (n = 10) received FP 250 microg/day and group 2 (n = 22) received montelukast 10 mg/day orally for 4 weeks. Sputum induction was repeated after the treatment period. The resulting cytospin slides were stained by Wright's stain and morphologic changes in apoptotic eosinophils were assessed by the use of light microscopy by two blinded expert pathologists. Serum soluble Fas ligand (sFasL) concentrations were measured by an ELISA method at baseline and after treatment in both groups, as well as in a group of healthy subjects. RESULTS: In within-group comparisons, the apoptotic ratio (AR) increased at the end of the study period in group 1 (p = 0.05). In the group treated with FP the ratio of sputum eosinophils significantly decreased (p = 0.02), and the AR significantly increased (p < 0.005). No differences were found in the two study groups in serum sFasL levels at the end of the treatment period compared with baseline values (p > 0.05). CONCLUSION: Our findings demonstrate that 4 weeks' treatment with a CysLT receptor antagonist (montelukast) resulted in an increase in eosinophil apoptosis comparable to that produced by FP, suggesting that induction of apoptosis may be a potential mechanism for the mode of action of CysLT receptor antagonists in asthma.
Asunto(s)
Acetatos/farmacología , Antiasmáticos/farmacología , Apoptosis/efectos de los fármacos , Asma/tratamiento farmacológico , Eosinofilia/tratamiento farmacológico , Eosinófilos/efectos de los fármacos , Antagonistas de Leucotrieno/farmacología , Quinolinas/farmacología , Esputo/citología , Acetatos/uso terapéutico , Adulto , Androstadienos/farmacología , Androstadienos/uso terapéutico , Antiasmáticos/uso terapéutico , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Asma/sangre , Asma/inmunología , Asma/patología , Ciclopropanos , Eosinofilia/sangre , Eosinofilia/inmunología , Eosinofilia/patología , Eosinófilos/patología , Proteína Ligando Fas , Femenino , Fluticasona , Volumen Espiratorio Forzado , Humanos , Antagonistas de Leucotrieno/uso terapéutico , Masculino , Glicoproteínas de Membrana/sangre , Persona de Mediana Edad , Variaciones Dependientes del Observador , Quinolinas/uso terapéutico , Método Simple Ciego , Sulfuros , Resultado del TratamientoRESUMEN
Background: Apoptosis may be important in limiting airway eosinophilia. Treatment with leukotriene antagonists decreases the number of eosinophils in both peripheral blood and sputum. Aim: To assess the effect of montelukast on eosinophil apoptosis in a group of patients with mild persistent asthma (MPA) and to compare this effect with the apoptotic effect of fluticasone propionate (FP). Methods: Randomly selected patients with MPA (n = 22) who had not taken anti-inflammatory therapy within the preceding 12 months were included in the study. The sputum induction procedure was performed and the patients were divided into two groups: group 1 (n = 10) received FP 250 mg/day and group 2 (n = 22) received montelukast 10 mg/day orally for 4 weeks. Sputum induction was repeated after the treatment period. The resulting cytospin slides were stained by Wrights stain and morphologic changes in apoptotic eosinophils were assessed by the use of light microscopy by two blinded expert pathologists. Serum soluble Fas ligand (sFasL) concentrations were measured by an ELISA method at baseline and after treatment in both groups, as well as in a group of healthy subjects. Results: In within-group comparisons, the apoptotic ratio (AR) increased at the end of the study period in group 1 (p = 0.05). In the group treated with FP the ratio of sputum eosinophils significantly decreased (p = 0.02), and the AR significantly increased (p 0.05). Conclusion: Our findings demonstrate that 4 weeks treatment with a CysLT receptor antagonist (montelukast) resulted in an increase in eosinophil apoptosis comparable to that produced by FP, suggesting that induction of apoptosis may be a potential mechanism for the mode of action of CysLT receptor antagonists in asthma
Contexto: La apoptosis puede ser importante para limitar los eosinófilos de las vías respiratorias. El tratamiento con antagonistas de los leucotrienos reduce el número de eosinófilos tanto en la sangre periférica como en el esputo. Objetivo: Evaluar el efecto del montelukast (M) sobre la apoptosis eosinofílica en un grupo de pacientes con asma leve persistente (ALP) para compararlo con el efecto apoptótico del propionato de fluticasona (PF). Métodos: Para el estudio se seleccionaron aleatoriamente pacientes con ALP (n = 22) que no habían recibido terapia antiinflamatoria durante los 12 meses previos. Tras proceder a la inducción del esputo, los pacientes se dividieron en dos grupos: uno recibió 250 mg/día de propionato de fluticasona (grupo 1, n = 10) y el otro 10 mg/día de M por vía oral (grupo 2, n = 12) durante 4 semanas. Tras el período de tratamiento se repitió la inducción del esputo. Los preparados resultantes obtenidos por citocentrifugación se tiñeron con colorante de Wright y dos patólogos expertos que desconocían el origen de las muestras las observaron al microscopio de luz para evaluar los cambios morfológicos de los eosinófilos apoptóticos. Se midieron las concentraciones séricas del ligando Fas soluble (sFasL) mediante el método ELISA antes y después del tratamiento en ambos grupos, midiéndose simultáneamente en un grupo de sujetos sanos. Resultados: Comparando los resultados en un mismo grupo, el índice apoptótico (IA) aumentó al final del período de estudio en el grupo 1 (p = 0,05). En el grupo tratado con PF, el índice de eosinófilos en el esputo disminuyó significativamente (p = 0,02), mientras que hubo un aumento significativo del IA (p 0.05). Conclusión: Nuestros hallazgos demuestran que un tratamiento de cuatro semanas con un antagonista de los receptores de Cis-LT, el montelukast, produce un aumento de la apoptosis eosinofílica comparable al que produce el propionato de fluticasona, lo que sugiere que la inducción de la apoptosis puede ser un mecanismo de acción de los antagonistas de los receptores de Cis-LT en el asma
Asunto(s)
Adulto , Humanos , Acetatos/farmacología , Antiasmáticos/farmacología , Apoptosis , Asma/tratamiento farmacológico , Eosinofilia/tratamiento farmacológico , Eosinófilos , Antagonistas de Leucotrieno/farmacología , Quinolonas/farmacología , Acetatos/uso terapéutico , Androstadienos/farmacología , Antiasmáticos/uso terapéutico , Antiinflamatorios/farmacología , Asma/sangre , Eosinofilia/sangre , Eosinofilia/inmunología , Antagonistas de Leucotrieno/uso terapéutico , Glicoproteínas de Membrana , Quinolonas/uso terapéuticoRESUMEN
BACKGROUND: Although complementary and alternative medicines are frequently used in Turkey, no studies with large series have yet been published. OBJECTIVE: Our aim was to determine the prevalences of the use of various types of complementary and alternative medicines in patients with asthma, seasonal allergic rhinitis (SAR) and chronic urticaria (CU) and the relationship between the use of these substances and patients' social, economic and demographic characteristics. METHODS: All patients completed a questionnaire about the use of complementary and alternative medicines, including herbal products, animal products, acupuncture, yoga, massage therapies, Turkish-baths, speleotherapy, and psychoreligious methods for curing their diseases. RESULTS: The overall use of complementary and alternative medicines was 38 %. The most common alternative therapy treatment was herbal therapy (30.5 %). The prevalence of the use of these therapies was higher in asthmatics than in patients with SAR and CU. In all patients, variables associated with the use of these therapies were older age and having asthma. Among asthmatics, the use of these therapies within the previous 12 months was higher in patients with hospitalization and acute attacks than in those without hospitalization or acute attacks. In this group important covariates in the use of complementary and alternative medicines were older age and severe disease. Approximately half of the patients and 41.2 % of asthmatics discontinued pharmacological therapy during alternative treatment or had not yet started it. CONCLUSION: Because of the high prevalence of the use of complementary and alternative medicines and the tendency to discontinue drug therapy during these treatments, patients should be educated about the importance of pharmacological therapies.
Asunto(s)
Terapias Complementarias/estadística & datos numéricos , Hipersensibilidad Inmediata/terapia , Enfermedad Aguda , Adulto , Factores de Edad , Antiasmáticos/uso terapéutico , Asma/epidemiología , Asma/psicología , Asma/terapia , Utilización de Medicamentos/estadística & datos numéricos , Femenino , Medicina de Hierbas , Hospitalización/estadística & datos numéricos , Humanos , Hipersensibilidad Inmediata/epidemiología , Hipersensibilidad Inmediata/psicología , Masculino , Persona de Mediana Edad , Pacientes Desistentes del Tratamiento/estadística & datos numéricos , Educación del Paciente como Asunto , Té , Turquía/epidemiologíaRESUMEN
Background: Although complementary and alternative medicines are frequently used in Turkey, no studies with large series have yet been published. Objective: Our aim was to determine the prevalences of the use of various types of complementary and alternative medicines in patients with asthma, seasonal allergic rhinitis (SAR) and chronic urticaria (CU) and the relationship between the use of these substances and patients' social, economic and demographic characteristics. Methods: All patients completed a questionnaire about the use of complementary and alternative medicines, including herbal products, animal products, acupuncture, yoga, massage therapies, Turkish-baths, speleotherapy, and psychoreligious methods for curing their diseases. Results: The overall use of complementary and alternative medicines was 38 %. The most common alternative therapy reatment was herbal therapy (30.5 %). The prevalence of the use of these therapies was higher in asthmatics than in patients with SAR and CU. In all patients, variables associated with the use of these therapies were older age and having asthma. Among asthmatics, the use of these therapies within the previous 12 months was higher in patients with hospitalization and acute attacks than in those without hospitalization or acute attacks. In this group important covariates in the use of complementary and alternative medicines were older age and severe disease. Approximately half of the patients and 41.2 % of asthmatics discontinued pharmacological therapy during alternative treatment or had not yet started it. Conclusion: Because of the high prevalence of the use of complementary and alternative medicines and the tendency to discontinue drug therapy during these treatments, patients should be educated about the importance of pharmacological therapies (AU)
Contexto: A pesar de que las medicinas complementarias y alternativas (MCA) se emplean con frecuencia en Turquía, hasta el momento no existen muchos estudios publicados. Objetivo: Nuestro propósito era determinar la prevalencia de los diferentes métodos de MCA en pacientes con asma, rinitis alérgica estacional (RAE) y urticaria crónica (UC), así como su relación con las características sociales, económicas y demográficas de los pacientes. Métodos: Todos los pacientes rellenaron un cuestionario sobre el uso de las MCA para la curación de sus enfermedades, en el que se contemplaban productos vegetales y animales, acupuntura, yoga, masaje terapéutico, baños turcos, espeleoterapia y métodos psicorreligiosos. Resultados: El total del uso de MCA resultó ser del 38 por ciento. Los productos vegetales eran el método de tratamiento alternativo más habitual (30,5 por ciento). La prevalencia del uso de MCA era mayor en los asmáticos que en los pacientes de RAE y UC. La edad avanzada y el asma estaban asociadas con el uso de MCA en todos los pacientes. En los asmáticos, el uso de MCA en los últimos 12 meses resultó superior en los pacientes que pasaron por una hospitalización o un ataque agudo que en los que no pasaron por esas situaciones. La edad avanzada y las enfermedades graves eran covariantes importantes del uso de MCA en este grupo. Aproximadamente la mitad de los pacientes y el 41,2 por ciento de los asmáticos habían dejado sus terapias farmacológicas durante el tratamiento alternativo, o bien utilizaban las MCA sin haber iniciado ninguna terapia farmacológica. Conclusión: Teniendo en cuenta la elevada prevalencia del uso de las MCA y la tendencia de los pacientes a interrumpir su terapia farmacológica durante esos tratamientos, es necesario educar a los pacientes sobre la importancia de las terapias farmacológicas (AU)
Asunto(s)
Masculino , Adulto , Femenino , Persona de Mediana Edad , Humanos , Enfermedad Aguda , Factores de Edad , Antiasmáticos , Asma , Terapias Complementarias , Utilización de Medicamentos , Hospitalización , Té , Hipersensibilidad Inmediata , Medicina de Hierbas , Educación del Paciente como Asunto , Turquía , Pacientes Desistentes del TratamientoRESUMEN
OBJECTIVES: Hypoxaemia occurring during haemodialysis has long been known. Several mechanisms in the pathogenesis have been proposed. The present study was conducted to test whether changes in pulmonary alveolar permeability were among the operating mechanisms. MATERIALS AND METHODS: Twenty haemodialysis patients (12 male, 8 female) were included in the study. The mean age was 49 years (age range: 18-85 years). Patients with known pulmonary disease, current smokers and those gaining more than 1 kg weight during the interdialytic period were excluded. Complete blood count, arterial blood gas analysis, pulmonary function tests and Tc-99m diethylene triamine pentaacetate (DTPA) inhalation scintiscan were carried out before and after haemodialysis. A bronchial provocation test was carried out after each session. A postero-anterior chest radiogram was taken for each patient. RESULTS: When the results before and after haemodialysis were compared, it was observed that the pH and serum bicarbonate levels, haemoglobin and haematocrit values were significantly higher after haemodialysis. However, the platelet count was found to be decreased significantly. Bronchial hyperreactivity, tested by metacholine, Was positive in 5 of 19 patients (26%). No correlation between bronchial hyperreactivity and other factors could be identified. No significant difference was observed in pulmonary Tc-99m DTPA clearance after haemodialysis. All chest radiograms were interpreted to be within normal limits. CONCLUSIONS: Since we observed no hypoxaemia following haemodialysis, we cannot comment as to whether the changes in pulmonary clearance play a role in the pathogenesis of haemodialysis-associated hypoxaemia. In order to reach reliable conclusions, additional studies are needed.
Asunto(s)
Alveolos Pulmonares/metabolismo , Diálisis Renal , Pentetato de Tecnecio Tc 99m/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Behçet's disease is a chronic multisystem vasculitis of unknown aetiology. This case report describes a patient who applied to the hospital because of dyspnoea, ascites, oedema of lower extremities and recurrent episodes of haemoptysis. For the last 12 yr, he had superior vena cava syndrome (SVCS) and cardiac and pulmonary involvement of Behçet's disease, and biochemical examination of ascite fluid yielded a chylous effusion containing triglyceride 421 mg dl-1 and cholesterol 49 mg dl-1. Chyloptysis was also detected by Sudan III stain. The patient died from cardiac tamponade in spite of cardiac fenestration. To the authors' knowledge, this is the first reported case of Behçet's disease with chylous ascites and chyloptysis in the English literature.